With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|The Role of Affective and Cognitive-Executive Processes and Structural Brain Abnormalities on Social Adjustment in Pediatric Brain Tumor Survivors||University of Calgary / Fiona Schulte, PhD||Psychosocial Grants||2016||Alberta|
|Targeting PLK1 as a Common Mechanism in Ph-like ALL||University of Texas M.D. Anderson Cancer Center / Joya Chandra, PhD||Reach Grants||2016||Texas|
|Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations||Stanford University / Ravi Majeti, MD/PhD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||California|
|Developing and Distributing a Pediatric Spinal Cord High-grade Glioma Model||Stanford University / Michelle Monje, MD/PhD||Innovation Grants||2016||California|
|Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model||Stanford University / Michelle Monje, MD/PhD||Innovation Grants||2016||California|
|GeneEditing in T cell Leukemia to Promote Immunomodulatory Forms of Cell Death||Boston Children’s Hospital / Dr. Ben Croker, PhD||Innovation Grants||2016||Massachusetts|
|Modeling RUNX1-Associated Clonal Hematopoietic Disorders in Zebrafish||Boston Children’s Hospital / Leonard Zon, MD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||Massachusetts|
|Targeted Inhibition of Lin28/let-7 Binding to Treat Pediatric Malignancy||Boston Children’s Hospital / George Q. Daley, MD/PhD||Innovation Grants||2016||Massachusetts|
|Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML||Boston Children’s Hospital / Alan Cantor, MD, PhD||RARE Grant Program (Research Accelerating RUNX1 Exploration)||2016||Massachusetts|
|Selective Epigenetic Regulation of Notch1 in T-cell Acute Lymphoblastic Leukemia||University of Michigan / Mark Yat-Fung Chiang, MD/PhD||Innovation Grants||2016||Michigan|